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Background: Recruiting stroke patients into acute treatment trials is challenging because of the urgency of clinical
diagnosis, treatment, and trial inclusion. Automated alerts that identify emergency patients promptly may improve
trial performance. The main purposes of this project were to develop an automated real-time text messaging
system to immediately inform physicians of patients with suspected stroke and to test its feasibility in the
emergency setting.
Methods: An electronic standardized stroke algorithm (SSA) was implemented in the clinical information system
(CIS) and linked to a remote data capture system. Within 10 minutes following the documentation and storage of
basic information to CIS, a text message was triggered for patients with suspected stroke and sent to a dedicated
trial physician. Each text message provided anonymized information on the exact department and unit, date and
time of admission, age, sex, and National Institute of Health Stroke Scale (NIHSS) of the patient. All necessary
information needed to generate a text message was already available – routine processes in the emergency
department were not affected by the automated real-time text messaging system. The system was tested for
three 4-week periods. Feasibility was analyzed based on the number of patients correctly identified by the SSA
and the door-to-message time.
Results: In total, 513 text messages were generated for patients with suspected stroke (median age 74 years
(19–106); 50.3% female; median NIHSS 4 (0–41)), representing 96.6% of all cases. For 48.3% of these text messages,
basic documentation was completed within less than 1 hour and a text message was sent within 60 minutes after
patient admission.
Conclusions: The system proved to be stable in generating text messages using IT-based CIS to identify acute
stroke trial patients. The system operated on information which is documented routinely and did not result in a
higher workload. Delays between patient admission and the text message were caused by delayed completion of
basic documentation. To use the automated real-time text messaging system to immediately identify emergency
patients suitable for acute stroke trials, further development needs to focus on eliminating delays in documentation
for the SSA in the emergency department.
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Table 2 Number of patients recruited by the trial team
per year
2010 2011 2012 2013
Interventional trials 69 45 239 263
Observational trials 1,043 1,213 500 464
Registries 40 53 27 17
Total 1,152 1,311 766 744
Table 3 Number of patients recruited by the trial team
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Effective therapy of acute stroke is limited to the first
few hours after stroke onset. Upon hospital arrival, the
diagnostic workflow is of highest priority and treatment
needs to be initiated as soon as possible [1]. Acute treat-
ment trials offer additional therapeutic options for stroke
patients. For hospital staff, however, identifying the pa-
tients who meet eligibility criteria for acute stroke trials
within minutes can be challenging [1,2]. Even in active
academic centers the number of eligible patients is lim-
ited [3,4], and only one third of acute treatment trials re-
cruit the targeted number of patients within the time
originally planned [5]. Thus, improving the recruiting
process is of supreme importance. Lack of time in the
emergency setting is one of the obstacles for the identifi-
cation of acute trial patients [6].
A dedicated trial team, including trial physicians and
trial assistants, was formed to improve trial performance
in our hospital. The team recruits about 500 patients per
year for clinical trials. Tables 1, 2 and 3 provide detailed
information on the relevant studies and their corre-
sponding inclusion rates.
To ensure that the trial physician on duty is rapidly
notified when a patient arrives in the emergency depart-
ment (ED), we implemented an automated screening
tool that transmits the relevant data via text messaging
to a mobile phone. In contrast to other automated
screening systems we wanted to minimize time delay be-
cause acute interventional stroke trials are often limited
up to 6 hours [7-9] or 9 hours [10,11] from symptom
onset. Even for interventional stroke trials that include
patients up to 24 hours [12] from symptom onset or
when eligibility is based on imaging criteria [12,13], an
immediate notification is necessary to guarantee that pa-
tient treatment is initiated promptly.
Here, we report on the technical development and
organizational feasibility of an automated stroke alerting
tool for emergency stroke patients.
Methods
An electronic standardized stroke algorithm (SSA) con-
sisting of a standardized stroke documentation sheet
(SSS) and a text message sent to the study physician’s
mobile phone was implemented in 2010; Table 4 pro-
vides more information on the SSS. As soon as a patient
is registered in the ED as a patient with suspectedTable 1 Number of studies conducted by the stroke trial
team per year
2010 2011 2012 2013
Interventional trials 10 10 9 6
Observational trials 16 19 16 17
Registries 1 1 1 1stroke, the stroke sheet is compiled by the clinical infor-
mation system (CIS). The SSS has to be completely filled
out before the ED registration process can be closed. It
contains routinely documented information on socio-
demographic data such as age, sex, clinical status, date,
time, and department and unit of admission, as well as
information on stroke severity by the National Institute
of Health Stroke Scale (NIHSS). No additional informa-
tion is needed.
The notification tool requires an IT-based ED docu-
ment which is capable of automatically transmitting the
patient information according to the HL7 standard. Text
messages based on anonymized patient information are
provided by a third-party telecommunications company.
Once the SSS is completed, the data is filed in CIS
(Figure 1). The CIS server is polled by the interconnec-
tion gateway every 10 minutes and retrieves data from
the central medical information system. To comply with
German regulations on data protection and data privacy,
this personalized data is sent to an internal filter server
which provides an anonymous dataset according to diag-
nostic criteria and sender. An event recognized as a
probable stroke is immediately forwarded as a text mes-
sage to the study physician on call and to the consultant
neurologists via an external provider. The text message
includes anonymized information on the hospital depart-
ment and unit as well as the acute stroke patient’s sex,
age (in years), date and time of admission, and NIHSS.
The electronic standardized stroke algorithm was
tested at the three campuses of the Charité University
Hospital in Berlin. Altogether, about 2,000 patients with
suspected stroke are admitted to the Charité every year.
Table 5 provides details on each of the three campuses.
Technical and organizational feasibility of the SSA was
tested by cohort analysis. For technical stability, weclassified by time of symptom onset
2010 2011 2012 2013
Acute (<9 h) 27 52 14 41
Subacute (<36 h) 191 156 112 65
Subacute (<72 h) 61 41 27 86
Other 873 1,062 613 552
Total 1,152 1,311 766 744




by admitting medical staff
Information documented
by ED neurologist
- name - current complaints - general evaluation incl.
neurological examination
- date of birth - description of symptoms - tentative diagnosis (ICD-10-Code)
- sex - medical history - indicated diagnostics (e.g., imaging)
and results





- vital signs - recommendations, for example
admission to stroke unit
- date and time (d&t) of
hospital admission
- concomitant medication - NIHSS incl. single sub-points**
- d&t of first contact with physician - leading symptoms (selection via radio button): - information about stroke/TIA
(selection via radio button):**
- means of patient transport
to hospital (e.g., ambulance)
- no information - no stroke or TIA
- stomach ache - stroke with alarm***
- chest ache - stroke without alarm
- dyspnea - TIA
- stroke/transient ischemic attack (TIA)* - d&t alarm**
- headache - d&t symptom onset or d&t last seen well**
- none of these symptoms - information about thrombolysis:**
- yes/no
if yes: d&t start of thrombolysis;
if no: reason why not: (textfield)
*This selection triggers a new form for stroke-specific information, the standardized stroke sheet. Patients with suspected stroke/TIA will be examined by a
neurologist.
**Standardized stroke sheet (SSS).
***Alarm will inform involved facilities (e.g., imaging unit, stroke unit, laboratory etc.) immediately. Information is sent by an automatic telephone chain.
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the system. For the organizational benefit of the system,
door-to-message times and the number of correctly
identified stroke-patients were examined. To monitor
the completeness of the identified patients list, a manual
screening of acute stroke patients was conducted by a
trial physician. To balance cohort analysis, we compared
datasets of consecutive patients during three months
with empirically high (November), average (April), and
low (June) stroke incidence rates [14]. To check inter-
variability between cohorts, patients’ demographic data
such as median age, sex, and median NIHSS, were
analyzed.Results
To evaluate the feasibility of the electronic SSA, we ana-
lyzed exemplary text messaging alerts from three con-
secutive cohorts with a total of 513 alarms (November,
n = 194; April, n = 183; July, n = 136). Median age in
these cohorts was 74 years (Interquartile range (IQR),
63–81), 50.3% were female (n = 258), median NIHSS was
4 (IQR, 1–8). There were no significant differencesbetween the three cohorts (Table 6) that were relevant
for our analysis.
In the period of investigation, a total of 595 patients
were diagnosed at admission with suspected stroke (is-
chemic or hemorrhage) in CIS. For 48 patients, the ori-
ginal diagnosis was refuted by the ED consultant, for 16
patients no standardized stroke sheet was compiled by
CIS (patients were admitted to adjacent departments
where SSA is not implemented). A text message to a
mobile phone was correctly sent in 513 (96.6%) of the
remaining 531 patients with suspected stroke. For 15
patients, no text message was generated because of
hospital-wide technical modifications in CIS that af-
fected the filter settings. For 3 patients, no text message
was triggered.
Median time from admission to text-messaging was 62
minutes (IQR, 32–118) with 48.3% (n = 239) dispatched
messages in less than 60 min and 27.3% (n = 135) within
60 to 120 minutes.
Discussion
We demonstrate that a SSA that includes an automated
























Figure 1 Overview of the Standardized Stroke Algorithm (SSA) and the resulting text message. (1) Physicians at the different EDs
document routine clinical data in the electronic Standard Stroke Sheet (SSS) at the clinical workstations. (2) Data is saved and made available to
interconnect by the clinical information system (CIS). (3) The CIS-server is polled by the e-Gate (interconnection gateway) every 10 minutes and
data is retrieved from the CIS. (4) The filter server provides anonymous data and is controlled by a service desktop to adjust the filter settings. (5)
The external provider sends the anonymized data to the (4a) pre-assigned recipients. (6) Screenshot of exemplary text messages received on
mobile phone on January 8th, 2013, with information about hospital site and department as well as patient’s sex, age, date and time of admission,
and NIHSS score. While the SSA operates on personalized patient data within the Charité intranet, no personal data is transmitted via internet.
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stability. Only on two consecutive days were text mes-
sages (15 = 3.4%) missed as a result of technical modifi-
cations in CIS. As these adaptions were not made
known to the users beforehand, no adjustments had
been carried out in advance on our filter settings. Imme-
diately after notification of CIS changes, filter settings
were modified. No text messages were missed after these
modifications.
In contrast to previous investigations [15-17], our ap-
proach was to focus on the special requirements for
acute trials, which mandate start of treatment within a
very limited time window: within 6 or 9 hours of symp-
tom onset. To comply with selection criteria, patients
must be screened immediately on arrival in hospital. In
addition, relevant information, e.g., NIHSS, is essentialTable 5 Information on campuses and admitted patients
CCM
Geographical location Middle of Berlin (0
Number of patients with suspected stroke per year approx. 400
CCM: Charité Campus Mitte; CVK: Campus Virchow Klinikum; CBF: Campus Benjaminfor reaching a decision regarding a patient’s trial
eligibility.
The SSA was implemented in the screening process of
the neurological department and was designed as a tech-
nical interface to achieve rapid interaction between the
physician on-call – who is responsible for routine diag-
nostic and treatment – and a specialized trial team phys-
ician. The SSA was based on information routinely
documented in CIS and thus did not entail a higher
workload for the treating physician. We think that this is
of utmost relevance for the acceptance and feasibility of
our screening tool in the emergency setting.
In contrast to other approaches, where selection cri-
teria had to be defined beforehand to identify patients
for specific trials [18], our method aimed at a more gen-
eral technique: every single patient with suspected strokeCVK CBF
km) About 3 km to the northwest About 10 km to the south
approx. 600 approx. 1,000
Franklin.
Table 6 Demographics, NIHSS, and stroke subtype of patients identified by SSA (n = 513)
Total November 2010 April 2011 June 2011 P
Text messages sent (n) 513 194 183 136
Age, median (IQR) 73 (63–81) 74 (66–82) 73 (65–82) 72 (57–80) 0.05
Female sex,% (n) 50.3 (258) 55.2 (107) 51.4 (94) 41.9 (57) 0.06
NIHSS, median (IQR) 4 (1–8) 4 (1–9) 3 (1–8) 4 (1–7) 0.90
Time from admission to triggered text message (TTM), median in min (IQR) 62 (32–118) 61 (31–108) 64 (35–117) 66 (20–129) 0.39
Tentative diagnosis at admission 0.56
Ischemic stroke,% (n) 69.4 (356) 68.0 (132) 68.3 (125) 72.8 (99)
Hemorrhages,% (n) 6.4 (33) 9.8 (19) 4.4 (8) 4.4 (6)
TIA,% (n) 13.1 (67) 10.8 (21) 15.8 (29) 12.5 (17)
Others,% (n) 11.1 (57) 11.3 (22) 11.5 (21) 10.3 (14)
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most relevant screening data was generated. Text mes-
sages were sent to the trial physician on call, who was
responsible for the screening and recruitment process
for a multitude of stroke trials. Based on the information
provided – patient sex and age, date and time of admis-
sion, and NIHSS – the trial physician pre-selected the
most likely eligible patients for a variety of stroke trials.
Naturally, a detailed screening process followed: the
screening information supported the trial physician in
deciding which patient to see first, i.e., in which case
time was most pressing.
As in previous approaches, some patients were identi-
fied by the automated screening system which had not
been identified in a manual search [16-18]. However, a
further analysis showed that these additional patients
were stroke mimics or were not admitted to our depart-
ment, and were thus not eligible for acute stroke trials.
An advantage of our reporting tool was that absolutely
all stroke patients were reported to the trial physician.
Even patients who failed to meet inclusion criteria at ad-
mission were recorded and surveyed later to catch
changes in medical condition, e.g., in NIHSS, and later
trial eligibility.
As our alerting system did not depend on specific se-
lection criteria, it was easily expanded for new trials or
after modification of selection criteria in ongoing trials;
no adaptions to the system were necessary. This was es-
pecially advantageous for repeated changes in selection
criteria or for high turnover of trials.
The main focus of our approach was not only on cap-
turing absolutely all patients but also generating the most
rapid alert possible. However, the time from admission to
text-messaging still exceeds 60 minutes in the majority of
patients, which is rather long. In the emergency setting,
documentation had to take second place to acute diagno-
sis and treatment. This led to delays in documentation
and is in fact the major obstacle to using the automated
screening tool for acute stroke intervention trials; for trialswith a very limited time window, delays exceeding 60 mi-
nutes post-hospital admission can reduce trial eligibility.
Nevertheless, in our case, delays were due not to technical
flaws but rather to suboptimal organization. We aim to
solve this problem with better training for the physicians
in ED. Nonetheless, we have to take into account that de-
lays in documentation will continue because therapy and
treatment are more relevant for the patient than data
documentation. In addition, future adaptions to the stan-
dardized stroke sheet will be mainly in the area of supple-
mentary information (e.g., time of symptoms onset) for
the screening process and the decision on trial eligibility.
A major benefit of the automated screening tool is its
availability outside regular working hours. In our survey,
118 (23.0%) patients were admitted at weekends and a
further 127 (24.8%) on working days between 6 pm and
6 am. We estimate that the majority of these 245 (47.8%)
patients would not have been screened at all for trial eligi-
bility without the automated notification tool.
Additionally, the notification tool might be of interest
as an automated alerting system for patients with sus-
pected stroke in standard care as the tool could inform
all relevant services within minutes once an appropriate
trigger is determined. The screening tool requires an IT-
based ED file and HL7. As HL7 is highly available in
most systems, the tool could be used at other hospitals
as well. Costs of the notification system depend on the
number of sent text messages and the specified charges.
Limitations
We deliberately did not perform a comparison of total
trial recruitment numbers with or without the notifica-
tion tool, so no quantitative correlation for total recruit-
ing numbers is provided.
Conclusions
Our SSA including an automated text message to a mo-
bile phone for acute stroke patients was technically
stable and feasible. Data protection rules and privacy
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gency setting were not affected. Nevertheless, documen-
tation in the ED needs to be sped up to minimize delay
between patient admission and text message or real-time
screening of trial eligibility. An IT-based ED file and
HL7 are required. As both are readily available in the
clinical setting, the notification tool can be set up else-
where. The benefits of the automated alerting tool are
that its technical prerequisites are readily available and
that it provides full documentation, can be utilized even
outside working hours, is low in cost, and can be inte-
grated into routine ED processes.
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